CMT-3 nanoformulations for systemic and local administration for inflammation control
The technology introduces innovative telodendrimer nanoformulations of the anti-inflammatory agent CMT-3 that enhance its solubility and bioavailability for effective systemic and local inflammation control.
Background:
CMT-3 is a potent anti-inflammatory compound with promising therapeutic potential; however, its poor water solubility significantly...
Published: 6/21/2026
|
Inventor(s): Juntao Luo, Robert Cooney, Qinghe Meng, Xiaojing Wang, Dandan Guo, Gary Nieman
Keywords(s): Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications > Biomedical Science and Engineering
|